Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “modified”

433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 433
Index total 30,257
Page 12 / 19

Quick answer

This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

433 results for “modified” · 30,257 patents in full index Clear search

  1. US 9290760

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  2. US 9278987

    Functionally-modified oligonucleotides and subunits thereof

    Sarepta Therapeutics, Inc. · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted

  3. US 9266931

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

  4. US 9265818

    Genetically modified Babesia parasites expressing protective tick antigens and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

  5. US 9260493

    Transducible delivery of nucleic acids using modified dsRNA binding domains

    The Regents of the University of California · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted

  6. US 9248119

    Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted

  7. US 9238803

    Modified zinc finger binding proteins

    Sangamo Biosciences, Inc. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  8. US 9234187

    Modified zinc finger binding proteins

    Sangamo Biosciences, Inc. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted

  9. US 9234188

    Modified zinc finger binding proteins

    Sangamo Biosciences, Inc. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted

  10. US 9226970

    Oligomer modified diaromatic substituted compounds

    Nektar Therapeutics · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted

  11. US 9192578

    Hot-melt extrusion of modified release multi-particulates

    The Board of Regents of the University of Texas System · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  12. US 9145552

    Modified factor X polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  13. US 9139644

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  14. US 9139833

    Modified small interfering RNA molecules and methods of use

    Arrowhead Research Corporation · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  15. US 9133480

    Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  16. US 9133478

    Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  17. US 9128080

    Modified T cell receptors and related materials and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  18. US 9119791

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  19. US 9121016

    Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

    Regents of the University of Minnesota · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  20. US 9119792

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  21. US 9114085

    Modified release pharmaceutical compositions of dexlansoprazole

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  22. US 9102938

    2′ and 5′ modified monomers and oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  23. US 9084808

    Modified small interfering RNA molecules and methods of use

    Arrowhead Research Corporation · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  24. US 9051379

    Sp1 polypeptides, modified Sp1 polypeptides and uses thereof

    Fulcrum SP Ltd. · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.